TUB-040

N/A

Report date: 2024/06/28 09:17:54

Base Information

Drug NameTUB-040
Drug Alias NameTUB-040
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUkraine +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTubulis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb CompanyTubulis GmbH
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A